​

Funding Round

Series B - Enveda Biosciences

Series B - Enveda Biosciences

Investment Firm

Overview

Enveda Biosciences is a biotechnology company engineering new drugs from plants.

Announced Date

Apr 20, 2023

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Kinnevik

Kinnevik

Kinnevik is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

6

Investor Name
Participant InvestorDimension
Participant InvestorWireframe Ventures
Participant InvestorHenry Kravis
Participant InvestorKinnevik
Participant InvestorTrue Ventures

Round Details and Background

Enveda Biosciences raised $51000000 on 2023-04-20 in Series B

Enveda Biosciences is a biotechnology company engineering new drugs from plants.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 21, 2022
Series B - Enveda Biosciences
12-55.0M
Dec 21, 2022
Debt Financing - Enveda Biosciences
1-13.0M
Apr 20, 2023
Series B - Enveda Biosciences
6-51.0M
Jun 14, 2024
Series B - Enveda Biosciences
9-55.0M

Recent Activity

There is no recent news or activity for this profile.